Lilly(Eli) & Co (NYSE: LLY) has a higher price-to-earnings ratio of 76.36x compared to its average ratio. LLY has 36-month beta value of 0.47. Analysts have mixed views on the stock, with 17 analysts rating it as a “buy,” 8 as “overweight,” 4 as “hold,” and 1 as “sell.”
The public float for LLY is 849.99M, and currently, short sellers hold a 0.76% ratio of that float. The average trading volume of LLY on April 29, 2025 was 3.66M shares.
LLY) stock’s latest price update
The stock price of Lilly(Eli) & Co (NYSE: LLY) has dropped by -0.82 compared to previous close of 884.54. Despite this, the company has seen a gain of 7.25% in its stock price over the last five trading days. seekingalpha.com reported 2025-04-28 that Eli Lilly and Company’s orforglipron generated positive results in the phase 3 trial in type 2 diabetes patients. The results look good or better than oral semaglutide (across trials) and similar to injectable semaglutide. The importance of these LLY results cannot be understated, as this should be the first oral obesity product that can be produced at scale to satisfy global demand.
LLY’s Market Performance
LLY’s stock has risen by 7.25% in the past week, with a monthly rise of 6.77% and a quarterly rise of 8.55%. The volatility ratio for the week is 3.13% while the volatility levels for the last 30 days are 4.39% for Lilly(Eli) & Co. The simple moving average for the past 20 days is 10.93% for LLY’s stock, with a 3.81% simple moving average for the past 200 days.
Analysts’ Opinion of LLY
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see LLY reach a price target of $975. The rating they have provided for LLY stocks is “Overweight” according to the report published on April 22nd, 2025.
BofA Securities gave a rating of “Buy” to LLY, setting the target price at $997 in the report published on December 10th of the previous year.
LLY Trading at 5.31% from the 50-Day Moving Average
After a stumble in the market that brought LLY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.79% of loss for the given period.
Volatility was left at 4.39%, however, over the last 30 days, the volatility rate increased by 3.13%, as shares surge +6.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.62% upper at present.
During the last 5 trading sessions, LLY rose by +7.25%, which changed the moving average for the period of 200-days by -6.65% in comparison to the 20-day moving average, which settled at $790.83. In addition, Lilly(Eli) & Co saw 13.64% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LLY starting from DONALD ZAKROWSKI, who proposed sale 2,000 shares at the price of $821.86 back on Mar 13 ’25. After this action, DONALD ZAKROWSKI now owns shares of Lilly(Eli) & Co, valued at $1,643,720 using the latest closing price.
Zakrowski Donald A, the SVP, Finance, & CAO of Lilly(Eli) & Co, sale 1,000 shares at $818.24 during a trade that took place back on Mar 13 ’25, which means that Zakrowski Donald A is holding 5,840 shares at $818,240 based on the most recent closing price.
Stock Fundamentals for LLY
Current profitability levels for the company are sitting at:
- 0.37 for the present operating margin
- 0.81 for the gross margin
The net margin for Lilly(Eli) & Co stands at 0.24. The total capital return value is set at 0.33. Equity return is now at value 84.84, with 14.84 for asset returns.
Based on Lilly(Eli) & Co (LLY), the company’s capital structure generated 0.7 points at debt to capital in total, while cash flow to debt ratio is standing at 0.26. The debt to equity ratio resting at 2.35. The interest coverage ratio of the stock is 22.58.
Currently, EBITDA for the company is 15.23 billion with net debt to EBITDA at 1.94. When we switch over and look at the enterprise to sales, we see a ratio of 19.14. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.15.
Conclusion
To put it simply, Lilly(Eli) & Co (LLY) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
